◼ Archived
Business
China Plans AI Tech Export Curbs to Manage Security Risks
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Biopharma
8 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Xenon pauses phase 3 depression trials after psychosis events
Xenon shares fall as phase 3 depression trials are paused following psychosis events.
◼ Archived
Business
Updated: Electra says $350M IPO will help it become a commercial biotech
Immunology drugmaker Electra Therapeutics pursues an upsized $350 million initial public offering on Nasdaq under the ticker ETRA.
◼ Archived
Business
🔮 fades ✓
Takeda’s long-serving R&D chief Andy Plump to retire in wake of pipeline successes
Takeda Pharmaceutical's R&D chief Andy Plump is set to retire in June 2027 following a period of significant pipeline reorganization and regulatory success.
◼ Archived
Business
🔮 fades ✗
Cholesterol drug setback casts doubt over multibillion-dollar race
A failed Novartis clinical trial for a cholesterol drug has triggered a biopharma selloff and cast doubt on competing efforts by Amgen and Eli Lilly.
◼ Archived
Business
🔮 fades ✓
Vacant lab space, shrinking workforce put Mass. in ‘unique position’ for biotech bounceback
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambition
Anthropic is aggressively entering the biopharma sector through a 100-day sprint involving Nobel laureates, M&A activity, and new scientific AI tools.
◼ Archived
Business
🔮 fades
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
The FDA has launched the PreCheck pilot program with seven participants to accelerate and strengthen the domestic manufacturing of drugs in the United States.